FKDSF.US Fukuda Denshi Co., Ltd.
- Market cap
- USD 1.15B
- P/E
- 10.0x
- P/B
- 0.99x
- ROE
- 6.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is FKDSF.US undervalued?
Graham numberFKDSF.US trades 33.5% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Fukuda Denshi Co., Ltd. fundamental analysis
No fundamental analysis for Fukuda Denshi Co., Ltd. yet.
Fukuda Denshi Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Fukuda Denshi Co., Ltd.
Fukuda Denshi Co., Ltd. engages in the manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph and stress test products; patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems, such as data management software. The company was founded in 1939 and is headquartered in Bunkyo, Japan.
Full company profileFukuda Denshi Co., Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Fukuda Denshi Co., Ltd. annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 135B | 140B | 139B | 140B | 124B |
| Gross Profit | 70.4B | 74.4B | 73.8B | 76.5B | 67.3B |
| Operating Income | 24.1B | 26.5B | 25.9B | 26.6B | 18.4B |
| EBITDA | 34.6B | 36.7B | 37.7B | 39.0B | 19.8B |
| Net Income | 17.3B | 18.7B | 18.6B | 18.8B | 12.3B |
| EPS | 571 | 648 | 645 | 696 | 456 |
| Balance Sheet | |||||
| Total Assets | 207B | 209B | 221B | 225B | 229B |
| Total Liabilities | 43.9B | 40.1B | 39.7B | 36.6B | 37.4B |
| Shareholders' Equity | 163B | 169B | 182B | 189B | 192B |
| Cash & Short-term Investments | 68.0B | 60.2B | 72.4B | 65.7B | 67.5B |
| Cash Flow | |||||
| Operating Cash Flow | 23.1B | 23.9B | 33.0B | 29.3B | - |
| Capital Expenditure | 12.5B | 14.1B | 12.9B | 19.9B | 0.00 |
| Free Cash Flow | 10.6B | 9.79B | 20.1B | 9.38B | - |
| Ratios | |||||
| ROE | 10.6% | 11.1% | 10.2% | 10.0% | 6.4% |
| ROA | 8.4% | 8.9% | 8.4% | 8.3% | 5.4% |
| Net Profit Margin | 12.8% | 13.3% | 13.4% | 13.5% | 9.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Fukuda Denshi Co., Ltd. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- 30.2%
- Ex-dividend date
- Mar 30, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 5.68B | 210 | 30.2% |
| 2025 | JPY 5.52B | 191 | 29.7% |
| 2024 | JPY 5.49B | 191 | 29.4% |
| 2023 | JPY 5.25B | 174 | 30.4% |
| 2022 | JPY 4.56B | 151 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Fukuda Denshi Co., Ltd.
- Insiders 21.89%
- Institutions 26.03%
- Public & others 52.08%
- Shares outstanding 27.0M
- Free float 19.1M
Fukuda Denshi Co., Ltd. company profile
- Company name
- Fukuda Denshi Co., Ltd.
- Ticker
- FKDSF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 3,497
- Fiscal year end
- March
- Address
- 3-39-4 Hongo, Bunkyo, Japan, 113-8420
- Phone
- 81 3 3815 2121
- Website
- fukuda.com
About Fukuda Denshi Co., Ltd.
Fukuda Denshi Co., Ltd. engages in the manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph and stress test products; patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems, such as data management software. The company was founded in 1939 and is headquartered in Bunkyo, Japan.
Fukuda Denshi Co., Ltd. management
4- Mr. Daijiro ShiraiPresident & Director · born 1951
- Mr. Haruo OgawaMD, GM of Technology & Quality Assurance Division and Director · born 1957
- Mr. Kazuo GenchiMD, General Manager of Sales Headquarters & Director · born 1958
- Mr. Naoki HisanoMD & Director · born 1968